Ying Yuan

49PUBLICATIONS
119CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Evolutionary computationEnzymesCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (49)

|Sep 16, 2026
Oral KRAS G12D inhibitor GFH375 for previously treated advanced solid tumors with KRASG12D mutations: a phase 1 trial.

|Aug 31, 2026
First-line anlotinib versus bevacizumab plus CapeOX in RAS/BRAF wild-type unresectable metastatic colorectal cancer (ANCHOR): a multicenter, prospective, randomized, phase 3 trial.

|May 26, 2026
Durable Response to Selpercatinib in Metastatic Colorectal Cancer Harboring a Novel TIMM23B::RET Fusion: A Case Report.

|Apr 21, 2026
Amivantamab Monotherapy in Chemorefractory RAS/BRAF Wild-Type Metastatic Colorectal Cancer: Results From OrigAMI-1, an Open-Label, Phase Ib/II Study.

|Mar 14, 2026
Recoding multiple rare codons enables the simultaneous incorporation of up to five distinct noncanonical amino acids.

Yu Fang, Wei Yu, Junjie Li

|Nov 10, 2025
O-GlcNAcylation of SPOP regulates colorectal cancer progression and ferroptosis by mediating β-catenin degradation.

Xiuyuan Zhang, Yuwei Ding, Qizhen Ye

Pageof 9

Frequent Collaborators

5 joint publications

Ruihua Xu

5 joint publications

Shixian Lin

5 joint publications

Yulin Chen

4 joint publications

Kefeng Ding